May 16, 2012 – Silicon Bayou News
NuMe Health, the New Orleans-based biotech startup developing products that modify the bacteria that live in the gastrointestinal tract, today announced that it has closed a $1.5 million Series A financing.
NuMe Health Lands 1.5m Series A
Related Articles
New Technology Revolutionizes DNA Testing of Sexual Assault Samples
New technology revolutionizes DNA testing of sexual assault samples InnoGenomics SpermX™ delivers reliable results to solve sexual assault crimes NEW ORLEANS (March 28, 2023) – Addressing a long-term shortcoming in…
Local Biotech Company is Improving Clinical Care for Animals
Local Biotech Company is Improving Clinical Care for Animals PetVet Dx celebrated recent expansion and future plans at a community event Friday NEW ORLEANS (March 31, 2023) Local biotech company…
The New Orleans BioInnovation Center Welcomes Program Director
The New Orleans BioInnovation Center Welcomes Program Director Muieen Cader to coordinate capital access & experiential learning programming NEW ORLEANS (Feb. 9, 2023) — The New Orleans BioInnovation Center…